If a supplied lot fails agreed specifications, we’ll replace it at no cost or refund its purchase price in full.
Quality test failed? Free replacement or full refund.
Off-spec? Free replacement or full refund.
Reading a Peptide HPLC Trace — A 5-Minute Field Guide for Bench Scientists. Read our briefing →
Reading a peptide HPLC trace — a field guide. Read →
On reading HPLC traces. Read →
Reference standard · Research use only
GHRH analog · approved for HIV-associated lipodystrophy
Price, MOQ and lead time come in your written quote — usually within 24 hours. No account needed.
Compound facts
| Name | Tesamorelin |
|---|---|
| CAS number | 218949-48-5 |
| PubChem CID | 16137828 |
| Molecular formula | C221H366N72O67S |
| Molecular weight | 5135.9 g/mol |
| Sequence | (trans-3-hexenoyl)-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL |
| Appearance | White to off-white lyophilized powder |
| Purity specification (HPLC) | ≥ 99.0% |
| On every batch COA | RP-HPLC purity · ESI-MS identity · Bacterial endotoxin · Fill amount (content per vial) |
| On request | LC-MS/MS sequence confirmation · Net peptide content · Water content (Karl Fischer) · Counter-ion content (e.g. acetate, TFA) · Microbial limits |
| Storage | Room temperature, protect from light |
| Strengths per vial | 2 mg · 5 mg · 10 mg · 20 mg |
| Pack | 10 vials per kit |
| MOQ | On request |
| Lead time | 10–18 days |
| Use | Research use only — not for human or veterinary use |
Identity data from the Lyochem product catalogue, checked against PubChem and registry records. The batch COA of your lot is the record for that lot's results. How to verify a COA
Lot documentation
Values belong to the lot. Ask for the COA of the offered lot before you order.
Independent test fails? Full refund. How it works
Research documentation
Tesamorelin is supplied for laboratory research. Contact sales to confirm the available identity, purity, and lot records, and discuss the evidence your assay or method-development project requires.
Overview
Tesamorelin is a 44-residue GHRH analog bearing an N-terminal trans-3-hexenoyl cap that shields it from DPP-4 proteolysis and prolongs plasma exposure relative to native GHRH or unmodified Sermorelin. Distinct within its class, it is the sole FDA-approved GHRH analog, marketed as the finished drug Egrifta for reducing excess visceral abdominal fat in HIV-associated lipodystrophy. Ask sales for the COA matched to the offered Tesamorelin acetate lot and review the identity and purity work actually recorded there. If a buyer's written procedure requires added ESI-MS, RP-HPLC, LC-MS/MS, or other evidence, define the method, acceptance rule, sample, report, timing, and cost before quotation; a new supplier alone does not make duplicate testing mandatory. The material is typically ordered either as a standalone vial or as the pre-blended Tesamorelin + Ipamorelin product.
Applications & buyer fit
GH-axis peptides ship to research labs studying somatotropic-pathway pharmacology and related models. Ask sales for the matching batch COA. Sequence, counter-ion, or stability evidence beyond that record is included only when required by a written project scope and agreed before quotation.
Biotech R&D Groups
Preclinical biotech and pharmaceutical discovery teams sourcing characterized peptides for receptor-pharmacology, screening, and method-development campaigns.
Academic Laboratories
Universities, medical schools, and government research institutes qualifying a reference standard for a method-development or in vivo workflow.
Every lot has its own batch-specific CoA — RP-HPLC purity, ESI-MS identity, bacterial endotoxin and fill amount, plus any analytical scope agreed at quote stage — tied to the exact lot you receive.
Review a representative batch CoA before you order, so you can confirm the packet matches what your method or sponsor audit needs.
Supplied strictly as a research reagent to research institutions — not a finished dosage form and not for human administration. Buyer qualification runs at the inquiry stage.
Other formats

Tesamorelin is also kept as a solution in nasal spray bottles.
| Contents | 2 mg, 5 mg |
|---|---|
| Fill volume | 10 mL or 20 mL |
| Minimum | 10 bottles per content and volume |
| Stock | Held in the United States, shipped within the US |
Regulatory note
The finished Tesamorelin drug (Egrifta) is FDA-approved for HIV-associated lipodystrophy. Lyochem supplies the bulk active strictly for Research Use Only; buyers are responsible for verifying ingredient eligibility in their destination market.
Selected literature
Frequently asked questions
The N-terminal acyl modification shifts the intact mass well above the unmodified 1-29 backbone, so ESI-MS reading roughly 5135.8 Da against about 3358 Da for Sermorelin 1-29 is the primary identity signal, and confirming that the higher-mass species is the dominant peak rules out substantial unmodified contaminant. Mass alone, however, does not localize the acyl group to the correct terminus, so LC-MS/MS coverage of the N-terminal residues is added to show the hexenoyl sits where the structure requires rather than on an internal side chain.
Ask sales for the applicable batch COA first. If the buyer’s written procedure requires LC-MS/MS, endotoxin, microbial limits, or another expanded item, agree the method, reporting format, timing, and cost before quotation.
Yes: 2 mg, 5 mg, in 10 mL or 20 mL bottles, minimum 10 bottles per content and volume. This format is held in the United States and shipped within the US; contact sales for availability and a quotation.
Send any vial from your order to an independent laboratory of your choice. If the report shows the product does not meet the specification on its COA — purity below the stated minimum, or an identity that does not match — share the report with our sales team and we refund that product in full.
Related peptides
29-mer
GHRH 1-29 fragment
Also in nasal sprayAlso in capsules
Modified GRF 1-29 · GHRH analog
Also in nasal spray
Co-characterized GH-axis pairing (Tesamorelin + Ipamorelin)